Bernard A, Bouchot O, Hagry O, Favre J P
Service de Chirurgie Thoracique, Hôpital Universitaire, Dijon, France.
Eur J Cardiothorac Surg. 2001 Aug;20(2):344-9. doi: 10.1016/s1010-7940(01)00788-6.
The aim of this study is to identify the risk group of patients with T4 lung cancer who could more likely benefit from surgical resection.
Between January 1, 1990, and December 31, 1998, 77 patients underwent pulmonary resection for T4 lung cancer: lobectomy (n = 20), bilobectomy (n = 4) and pneumonectomy (n = 53). The T4 sites of mediastinal involvement were: Intrapericardiac portions of the pulmonary artery (n = 30), left atrium (n = 19), aorta (n = 8), superior vena cava (n = 8), carina (n = 7), the esophagus (n = 8) and the vertebral body (n = 6). Ten patients had multiple neoplastic nodules in the same lobe of the lung.
Overall survival rates at 1, 2 and 3 years were 46, 31 and 21%, respectively. Factors adversely affecting survival with univariate analysis included the localization of tumours in the lower lobe (P = 0.04) and both the involvement of superior and inferior mediastinal lymph nodes (P = 0.03). Multivariate analysis included two factors adversely affecting survival: the location of the primary tumour and the nodal stations involved. Regression tree analysis classified the patients into low-risk group (primary tumour in upper lobe or in main stem bronchus and pN0 or pN1 or superior or inferior mediastinal nodes involved), intermediate-risk group (primary tumour in upper lobe or in main stem bronchus and both superior and inferior mediastinal nodes involved, primary tumour in inferior lobe and pN0 or pN1 or inferior mediastinal nodes involved) and high-risk group (primary tumour in inferior lobe and both superior and inferior nodes involved). The 3-year survival rates were 36% for the low-risk group, 4% for the intermediate-risk group and 0% for the high-risk group (P = 0.006).
In patients with T4 lung cancer, the surgery can justify itself for tumours in the upper lobe or in the main stem bronchus and with pN0 or pN1.
本研究旨在确定更有可能从手术切除中获益的T4期肺癌患者的风险组。
在1990年1月1日至1998年12月31日期间,77例患者接受了T4期肺癌的肺切除术:肺叶切除术(n = 20)、双叶切除术(n = 4)和全肺切除术(n = 53)。纵隔受累的T4部位包括:肺动脉的心包内部分(n = 30)、左心房(n = 19)、主动脉(n = 8)、上腔静脉(n = 8)、隆突(n = 7)、食管(n = 8)和椎体(n = 6)。10例患者在同一肺叶有多个肿瘤结节。
1年、2年和3年的总生存率分别为46%、31%和21%。单因素分析中对生存有不利影响的因素包括肿瘤位于下叶(P = 0.04)以及上纵隔和下纵隔淋巴结均受累(P = 0.03)。多因素分析包括两个对生存有不利影响的因素:原发肿瘤的位置和受累的淋巴结站。回归树分析将患者分为低风险组(原发肿瘤位于上叶或主支气管且pN0或pN1或上纵隔或下纵隔淋巴结受累)、中风险组(原发肿瘤位于上叶或主支气管且上纵隔和下纵隔淋巴结均受累,原发肿瘤位于下叶且pN0或pN1或下纵隔淋巴结受累)和高风险组(原发肿瘤位于下叶且上纵隔和下纵隔淋巴结均受累)。低风险组的3年生存率为36%,中风险组为4%,高风险组为0%(P = 0.006)。
在T4期肺癌患者中,对于位于上叶或主支气管且pN0或pN1的肿瘤,手术是合理的。